The University of Alabama at Birmingham (UAB) has been awarded a $1,485,001 Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "Overcoming Perturbations that Orchestrate Immune Exhaustion and Dysfunction in Breast Cancer." The grant, awarded on March 1, 2025, will fund a 3-year research project focused on advancing therapeutic approaches for breast cancer by investigating how to restore effective immune responses. As a leading biomedical research institution, UAB will leverage its expertise in cancer biology, immunology, and translational research to develop innovative solutions that can improve health outcomes for military service members and the general public. This federal grant award further solidifies UAB's role as a key partner for the Department of Defense in addressing critical medical challenges through rigorous scientific investigation.
Generated 3/4/25, 8:49 AM